-+ 0.00%
-+ 0.00%
-+ 0.00%

MERCK & CO - REMIGROMIG DEMONSTRATES NON-INFERIOR VISUAL ACUITY VERSUS RANIBIZUMAB AT ONE YEAR IN DME

路透·10/10/2026 22:10:03

請登錄查看新聞詳情